These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 12764557

  • 1. A novel process for the production of a veterinary rabies vaccine in BHK-21 cells grown on microcarriers in a 20-l bioreactor.
    Kallel H, Rourou S, Majoul S, Loukil H.
    Appl Microbiol Biotechnol; 2003 Jun; 61(5-6):441-6. PubMed ID: 12764557
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Rabies veterinary virus vaccine produced in BHK-21 cells grown on microcarriers in a bioreactor.
    Gallegos Gallegos RM, Espinosa Larios EL, Ramos Ramírez L, Kretschmer Schmid R, Aguilar Setién A.
    Arch Med Res; 1995 Jun; 26(1):59-63. PubMed ID: 7711449
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of various serum and animal protein free media for the production of a veterinary rabies vaccine in BHK-21 cells.
    Kallel H, Jouini A, Majoul S, Rourou S.
    J Biotechnol; 2002 May 23; 95(3):195-204. PubMed ID: 12007860
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Production of rabies vaccine by an industrial scale BHK 21 suspension cell culture process.
    Pay TW, Boge A, Menard FJ, Radlett PJ.
    Dev Biol Stand; 1985 May 23; 60():171-4. PubMed ID: 3899780
    [Abstract] [Full Text] [Related]

  • 12. Development of a measles vaccine production process in MRC-5 cells grown on Cytodex1 microcarriers and in a stirred bioreactor.
    Trabelsi K, Majoul S, Rourou S, Kallel H.
    Appl Microbiol Biotechnol; 2012 Feb 23; 93(3):1031-40. PubMed ID: 21935589
    [Abstract] [Full Text] [Related]

  • 13. Immunogenicity and efficacy of an in-house developed cell-culture derived veterinarian rabies vaccine.
    Kallel H, Diouani MF, Loukil H, Trabelsi K, Snoussi MA, Majoul S, Rourou S, Dellagi K.
    Vaccine; 2006 May 29; 24(22):4856-62. PubMed ID: 16600442
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Adaptation of a Chinese ferret badger strain of rabies virus to high-titered growth in BHK-21 cells for canine vaccine development.
    Liu Y, Zhang S, Zhang F, Hu R.
    Arch Virol; 2012 Dec 29; 157(12):2397-403. PubMed ID: 22886183
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of rabies virus multiplication by siRNA delivered through adenoviral vector in vitro in BHK-21 cells and in vivo in mice.
    Sonwane AA, Dahiya SS, Saini M, Chaturvedi VK, Singh RP, Gupta PK.
    Res Vet Sci; 2012 Aug 29; 93(1):498-503. PubMed ID: 21767857
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.